Nearly 1 in 10 individuals with myalgic encephalomyelitis/chronic fatigue syndrome reported voice or speech changes in a recent survey, despite not being directly asked about these symptoms.
Subgroup analyses demonstrated a greater reduction in neurologic events than psychiatric events, though the reduction in psychiatric events was not statistically significant.
Researchers assess whether differences in control group outcomes across antidepressant trials reflect methodological variability, patient expectations, or limitations in blinding effectiveness.
A 3-year analysis of a phase IIIb trial found that bimekizumab, a dual interleukin-17A and interleukin-17F inhibitor, maintained high rates of skin clearance and demonstrated a consistent safety profile in patients with moderate-to-severe plaque psoriasis, including those who switched from secukinumab, an interleukin-17A inhibitor.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Not all screen time is created equal. That’s the message from a recent editorial, which challenges the idea that all forms of problematic internet use led to the same cognitive consequences.
Using Raman spectroscopy and based on extrapolated concentrations measured in residential and car cabin environments, researchers found that adults may inhale up to 68,000 microplastic particles daily from indoor air.
A new meta-analysis of 11 randomized controlled trials found that patients began regaining weight as early as 8 weeks after discontinuing anti-obesity medications, with weight gain continuing through 52 weeks.